PROJECT REPORT ON

TO ASSESS THE USAGE OF ALLOPATHIC AND AYURVEDIC PRODUCTS BY DIFFERENT DOCTORS

(THE VEIWS OF DOCTORS)

SUBMITTED TO:

SUBMITTED BY:

Mr. J.S.SAINI
SENIOR MANAGER MARKETING

LOVEKESH SARDA
REGD.NO:10806768 LOVELY PROFESSIONAL UNIVERSITY

IndSwift.ltd

TABLE OF CONTENTS
ACKNOWLEDGEMENT PREFACE

EXECUTIVE SUMMARY
CHAPTER 1. Introduction to study Review of literature CHAPTER 2 Company profile

CHAPTER 3
Objectives of the study Research methodology Research design Sample design and size Sources of data Scope of the study CHAPTER 4 Data analysis CHAPTER 5 Findings Recommendations Conclusion Questionnaire Bibliography

PREFACE
Our Institute has made a sincere effort in providing linkage between industry and students. Industrial Training is a platform for a student to supplement his theoretical knowledge with practical knowledge. The main purpose of Industrial Training is to get an exposure in industrial environment, which is not possible in classroom. The training also tells about the limitation of the knowledge of a person and helps in clearing the concept easily and effectively. The Industrial training also made me aware of the importance of discipline, punctuality, teamwork, sense of responsibility . I undertook my project at IndSwift. Ltd. It is a pioneer organization in manufacturing and supplying allopathic and ayurvedic drugs in India and to other countries. The training is definitely going to play an important role in developing an aptitude for handwork and self confidence for my successful future.

ACKNOWLEDGMENT
I am thankful to Mr. S.R.MEHTA who is chairman of the company for permitting me to complete the project in such a reputed company in the market. I would like to thank Mr. J.S. SAINI the project guide of industry who guide me how to work on project report. Helped me to choose the project topic and provide information time to time. I express an extreme sense of gratitude to Dr. JASDEEP DHAMI for their suggestions to me when I am needed. I wish to thanks the entire staff & workers of IndSwift. LTD for their suggestions, guidance & co-operation.

EXECUTIVE SUMMARY

PROJECT TITLE: EVALUATION STUDY TO ASSESS THE USAGE OF ALLOPATHIC AND

AYURVEDIC PRODUCTS IN VEIWS OF DOCTORS.

My project is to assess the usage of allopathic and ayurvedic by the doctors. In this survey I found very zigzag results. Every doctors have different type of way to heal particulars . Some doctors used their basic practices and some with combination therapy. This fact is totally depending on the regions. Interior area gives you the results for combination therapy, where developed cities provides the basic one . My project sampling was carried out in interior area of Hamirpur (H.P). and Chandigarh . Sample size is 20 ayush doctors and 20 allopathic doctors. Health care in Hamirpur and Chandigarh is provided by allopathic and traditional health care . These health care services are most effective if they are compatible with the needs and aspiration of the people . Allopathic and ayurveda services in Hamirpur and Chandigarh provided by private, compounders and health centers of govt. But the difference in Chandigarh and hamirpur is, in hamirpur due to socio-cultural and economics reasons a modern health care systems not widely prevalent. So they more depends on traditional systems of medicines. Even in developed country or world the use of complementary and alternative medicines has been steadily increasing in previous decades. The basic requirement for allopathic doctors is allopathy. But ayurveda doctors oftenly use the allopathic medicines on the customer preferences, first aid, in emergency. As large no: of accident occurs in daily life so besides giving ayurvedic medicines to patient these ayurveda doctors often have to take up the other modes of medication. Hence this point accepts the allopathic treatment is life saving drug in emergency. But for long term, safe, non toxic is herbal . This whole treatment is based on the diseases. When a patient is diagnosed with the medical problem, the allopathic doctors in audience with cunsultant of traditional therapy

decides on the treatment procedure. If the ailment is critical, the patient is sent to the allopathic doctors . For instance, if a person is suffering from asthma or bronchial pain or diabetes and is in early stages of diseases, allopathic medicines along with ayurveda can be suggested. In the way, modern medicines works to reach the disease while traditional one cure and cleanse the body. To comparison both system is impossible. But market survey has still weightage of allopathic. But ayurveda is on ignition stage.

OBJECTIVE OF THE STUDY:

1> To assess the usage of allopathic or ayurveda system by the doctors. 2> To study the preferences of the systems by the doctors taking the reasons as side effects, time duration, safety. 3> To study the availability the medicines in clinic or nearby retailers. 4> To know diversifying allopathic to ayurveda by industries is right step or not. 5> To study the order of preferences by the doctors towards the different medical professionals.

SCOPE OF THE STUDY:

The scope of study means the subject matter to be researched in the study . It defines the overall rationale of the study by explaining the geographically area of the study along with type of the data. In order to accomplish the objectives of the project . Survey conducted in Himachal Pradesh and Chandigarh to fill the questionnaire by the doctors which designed for the purpose of the survey . On the basis of data collected I analysis the result of the project .

RESEARCH METHODOLOGY
In order to gets information by various reasons the research methodology is as follows: DATA COLLECTION: Adequate and authentic data is the foundation stone for an analysis. It is very necessary that the data should be adequate and relevant so that the analysis which we derive from that data is exact. So data collection requires due attention and care. In order to get the required basic information

about the usage of medical system by doctors and for what disease . I relied on both primary data and secondary data.

PRIMARY DATA: Regular visit to the organization i.e.IndSwift Ltd. In Chandigarh and after regular visit to market and meetings with doctors was made to obtain the required information and learn about the market and organisation how it works. Interviews with the management officials and staff of the organization to get latest information.

SECONDARY DATA: Books, Magazines, Articles from internet etc. constitute the secondary sources of information for the project report.

SAMPLING PLAN: Universe : The population of study consists of hamirpur and chandigarh. Sample Size : Sample Sizes 40 respondants. 20 doctors of ayurveda and 20 from allopathic . Sampling Technique : I have used technique of convenience sampling. Geographical scope: Hamirpur (h.p) and Chandigarh . . Tool for data analysis : Percentage method for getting results. doctors and retailers (pharmacy shops) I

FINDINGS:
In my market survey I found weightage towards the allopathic products . 35% of allopathy doctors use ayurveda medicine in prescription but in case of ayurvedic doctors 80% of them , they are using allopathic medicine in prescription. I also find that the combination therapy made by doctors doing great job in healing the disease like coronary heart disease , cancer and many more chronicle diseases. upcoming one. As allopathic is first preference by the doctors but ayurveda is

RECOMMENDATION:
According to findings that in current scenario doctors and patient move towards the ayurveda but allopathic still rules. I would like to recommend IndSwift 1. Doctors have yet to find a solution for conditions like cancer pain and chronic pancreatitis in complementary therapies where modern interventional pain procedures are very effective. So herbal drugs use in cancer and heart disease is going to be popular for the doctors. This finding helps IndSwift to capture market by manufacturing of anti cancer herbal drug. 2. My findings helps IndSwift that it should work on herbal medicines but along with allopathic. 3. In future company get benefit if they prepare combination therapy medicines with no side effect and try to be 100% cure guarantee.

CHAPTER- 1 INTRODUCTION TO SUBJECT: AYURVEDA

Ayurveda (Devangar: , the 'science of life') is a system of traditional medicine native to India, and practiced in other parts of the world as a form of alternative medicine. In Sanskrit, the word Ayurveda comprises the words yus, meaning 'life' and veda meaning knowledge . Evolving throughout its history, Ayurveda remains an influential system of medicine in South Asia. The earliest literature of Ayurveda appeared during the Vedic period in India. The Sushruta Samhita and the Charaka Samhita were influential works on traditional medicine during this era. Ayurvedic practitioners also claim to have identified a number of medicinal preparations and surgical procedures for curing various ailments and diseases. As per Indian heritage and science "Ayurveda" is a Upa Veda or anexture of four main vedas(Knowledge Systems). the famous treaties of Ayurveda, "Charaka Samhita" by sage "Charakan", details the prevention and treatment of disease and "Sushruta Samhita" of Sage "Sushruta" deals Ayurvedic Surgical procedures. In Ayurvedic system, Prevention of all types of

disease have prominent place than treatment, including restructuring of life style to align with the course of nature and four seasons, which will guarantee complete wellness. Ayurveda is considered to be a form of complementary and alternative medicine (CAM) within the western world, where several of its methodssuch as herbs, massage, and Yoga as exercise or alternative medicineare applied on their own as a form of CAM treatment. Ayurveda believes in five great Elements (Devangar: ; earth, water, fire, air and space)-to compose the Universe, including the human body.Chyle, blood, flesh, fat, bone, marrow, and semen are believed to be the seven primary constituent elements (Devangar: ) of the body.Ayurveda stresses a balance of three substances: wind/spirit/air, phlegm, and bile, each representing divine forces. According to Ayurveda, these three regulatory principles--Doshas (Devangar: )vata (wind/spirit/air), pitta (bile) and kapha (phlegm)are important. Traditional beliefs hold that humans possess a unique constellation of Doshas. In Ayurveda, the human body perceives attributes of experiences as 20 Guna (Devangar: , meaning qualities).Surgery and surgical instruments are employed. It is believed that building a healthy metabolic system, attaining good digestion, and proper excretion leads to vitality. Ayurveda also focuses on exercise, yoga, meditation, and massage.Thus, body, mind, and spirit/consciousness need to be addressed both individually and in unison for health to ensue. The concept of Panchakarma (Devangar: ) is believed to eliminate toxic elements from the body. Eight disciplines of Ayurveda treatment, called Ashtanga (Devangar: ), are given below: Surgery (Shalya-chikitsa). Treatment of diseases above the clavicle (Salakyam). Internal medicine (Kaaya-chikitsa). Demonic possession (Bhuta vidya): Ayurveda believes in demonic intervention andas a

form of traditional medicineidentifies a number of ways to counter the supposed effect of these interferences.[13] Bhuta vidya has been called psychiatry. Pediatrics (Kaumarabhrtyam). Toxicology (Agadatantram). Prevention and building immunity (rasayanam). Aphrodisiacs (Vajikaranam). Ayurveda gained recognition in the Western world as

medical scholars, notably , Frank John Ninivaggi MD of Yale University School of Medicine, researched and outlined its various postulates in one major textbook form suitable to Western academic science. In the United States of America, the NIH NCCAM expends some of its $123 million budget on Ayurvedic medicine research. In India the government became involved in traditional drug production when the Central Drug Research Institute patented two new drugs from ancient Ayurvedic formulas. One, a mixture of black pepper, long pepper, and ginger, allows for the dosage of the antibiotic rifampicin to be halved in the treatment of tuberculosis and other mycobacterial infections. The other is a memory tonic produced from the traditional plant called brahmi. Overseas patenting of turmeric and products of the neem tree caused controversy in India and other nations. In August the U.S. Patent and Trademark Office canceled a U.S. patent on the wound-healing properties of turmeric when the Indian government proved that records had existed for this use for centuries.

ALLOPATHY
Allopathic medicine and allopathy (from Greek , llos, other, different + , pthos, suffering) are terms coined by Samuel Hahnemann, the founder of homeopathy. It meant "other than the disease" and it was intended, among other things, to point out how traditional doctors used methods that had nothing to do with the symptoms created with the disease, which meant that these methods were harmful to the patients. Originally intended as a characterization of standard medicine in the early 19th century, these terms were rejected by mainstream physicians and quickly acquired negative overtones. During the 19th century it was used widely among irregular doctors as a pejorative term for regular doctors.In the United States the term "allopathic" has been used by persons not related to homeopathy, but it has never been accepted by the medical establishment, and is not a label that such individuals apply to themselves. In the United States, allopathic medicine can sometimes refer to the medical training that leads to the degree Doctor of Medicine rather than the degree Doctor of Osteopathic Medicine, although this is uncommon. See comparison of MD and DO in the United States. Generally, allopathic medicine refers to "the broad category of medical practice that is sometimes called Western medicine, biomedicine, scientific

medicine, or modern medicine", with varying degrees of acceptance by medical professionals in different locales. In particular, the terms allopathic medicine and allopathy may be used for regular medicine in a context of traditional medicine such as Ayurveda as well as in a context of complementary and alternative medicine such as homeopathy (see homeopathy and allopathy). However, many aspects of traditional medicine systems such as Ayurveda or Traditional Chinese medicine are themselves allopathic in that they act by opposing the patient's symptoms.

SURVEY STUDY

Allopathy and ayurveda are as different as day and night, and hence the two sets of opposing views. However, if one has to compare ayurveda and allopathy on one platform, then such comparison might be a tad difficult. "Allopathy treats individuals as an independent physical entity like a machine. It is further sub-divided into various organs and systems looked after by different specialties. Whereas, ayurveda treats the individual as a whole, considering him to be a part of the universal whole . A positive aspect in the whole ayurveda vs allopathy issue, is the fact that, people are now open to know more about this ancient science. Also while there might not be prejudices or bias against the same, there are certain misconceptions, which can only be dispelled with knowledge and information dissemination. "There are no prejudices surrounding ayurveda. There may be misconceptions regarding its practice. If anything, the interest in this system of medicine has been growing rapidly both in the domestic and international market, attesting to its popularity and widespread acceptance. My project is to assess the usage of allopathic and ayurvedic by the doctors. In this survey I found very zigzag results. Every doctor have different type of way to heal particulars. Some doctors used their basic practices and some with combination therapy. This fact is totally depending on the regions. Interior area gives you the results for combination therapy, where developed cities provides the basic one. My project sampling was carried out in interior area of Hamirpur (h.p). and Chandigarh . Sample size is 20 ayush doctors and 20 allopathic doctors. Health care in hamirpur and Chandigarh is provided by

allopathic and traditional health care . These health care services are most effective if they are compatible with the needs and aspiration of the people . Allopathic and ayurveda services in Hamirpur and Chandigarh provided by private , compounders and health centers of govt. But the difference in Chandigarh and hamirpur is, in hamirpur due to socio-cultural and economics reasons a modern health care systems not widely prevelant. So they more depends on traditional systems of medicines . Even in developed country or world the use of complementary and alternative medicines has been steadily increasing in previous decades . The basic requirement for allopathic doctors is allopathy. But ayus doctors oftenly use the allopathic medicines on the customer preferences, first aid, in emergency. As large no: of accident occurs in daily life so besides giving ayurvedic medicines to patient these ayush doctors often have to take up the other modes of medication. Hence this point accepts the allopathic treatment is life saving drug in emergency. But for long term , safe , non toxic is herbal . This whole treatment is based on the diseases . When a patient is diagnosed with the medical problem, the allopathic doctors in audience with consultant of traditional therapy decides on the treatment procedure. If the ailment is critical, the patient is sent to the allopathic doctors. For instance , if a person is suffering from asthma or bronchial pain or diabetes and is in early stages of diseases , allopathic medicines along with ayurveda can be suggested . In the way, modern medicines works to reach the disease while traditional one cure and cleanse the body. To comparison both system is impossible. But market survey has still weightage of allopathic. But ayurveda is on ignition stage.

LITERATURE AND LITERATURE REVIEW

SHANKAR.R.V(2001):
A survey of drug use patterns in western Nepal Shankar PR, Kumar P, Theodore AM, Partha P, Shenoy N.,Dr.P.Ravi Shankar MD Mr.A.M.Theodore MSc Department of Pharmacology Department of Community

MedicineManipal College of Medical Sciences Manipal College of Medical Sciences Pokhara, Nepal. Pokhara, Nepal. Dr.Pawan Kumar MD Dr. Praveen Partha DNB Department of Community Medicine Department of Medicine Manipal College of Medical Sciences Manipal Teaching Hospital Pokhara, Nepal. Pokhara, Nepal Mr. Nagesh Shenoy M.Pharm Department of Community Pharmacy Manipal Teaching Hospital Pokhara, Nepal. Name of departments to which the work should be attributed: Departments of Pharmacology , Community medicine AND Internal medicine Manipal College of Medical Sciences Pokhara, Nepal. Name and address of corresponding author: Dr.P.Ravi Shankar , Department of Pharmacology , Manipal College of Medical Sciences P.O.Box 155 , Deep Heights Pokhara, Nepal. E-mail: mcoms@mos.com.np pathiyilravi@rediffmail.com Abstract: Background: In Nepal, traditional health care providers have an important role to play in the provision of health services. Non-doctor prescribing of allopathic medicines is commonly carried out by compounders, health assistants and other practitioners. Self-treatment in which herbal remedies play a large role is also common. Most of the previous studies have been carried out in the Kathmandu valley. As studies in the Pokhara valley are lacking the present study was carried out. Methods: The study was carried out in Pokhara sub-metropolitan city and the surrounding villages in the month of September 2001 using a semi-structured questionnaire by the health workers of the community medicine department. The pattern of drug use in the preceding 6 month period was noted. Differences in the proportion of patients using self-medication and

complementary medicines according to age, place of residence and socioeconomic status of family were analysed by the z test of proportions (p<0.05). Findings and conclusions: 112 households were surveyed during the study period. 120 individuals from these households had been prescribed medications during the study period. There was a total of 164 encounters with the health care system. Self-medication was practiced by 39 families during the study period. Home remedies accounted for 18.9 % of the drugs used. 71.6 % of the respondents using prescribed medications had used modern medicines. Self-medication was more common among rural households. Improving accessibility to medicines, improvement of the government health care system and greater integration of traditional and modern health care systems are recommended. Keywords: Drugs, medication-statistics. Introduction: Health care in Nepal is provided by both allopathic and traditional health care providers. Health care services are most effective if they are compatible with the needs and aspirations of the people. Allopathic services in Nepal can be provided by private practitioners, compounders and the government health centres. Compounders are usually persons without a formal medical education who have been working under a registered medical practitioner helping him prepare medicines, dressing the patients and doing other jobs in the clinic. They usually start their own clinics after gaining a few years experience. Traditional health care providers are classified as: a) Faith healers: 1) Dhami-Jhankri 2) Ojha 3) Pandit-Lama-Gubhaju-Pujari and 4) Jyotishi and b) Medical providers: 1) Baidhya-Kabiraj 2) Jadi-Buti wala.1 Dhami-jhankris are faith healers who by beating a drum and ritualistic chanting puts the patient into a trance. Pandit, Lama, gubhaju and pujaris are the priests of the different ethnic and religious groups of Nepal. Baidhyas and Kabiraj are ayurvedic practitioners who use herbs along with other elixirs, metal preparations etc. Jadibuti walas are herbalists who use only herbal preparations. In Nepal due to historical, socio-cultural and economic reasons a modern health care system is not widely prevalent. So there is an increased dependence on traditional systems of medicine. Even in the developed world the use of complementary and alternative medicines (CAM) has Drug-Monitoring-methods, Non-prescription-therapeutic use, Self-

been steadily increasing in the previous decade.2,3 In the developed countries, patients preferring CAM are generally female, of a high socio-economic class and with a more holistic approach to life.4,5 In Nepal about two decades ago studies has found that the hill people turned to their Dhami-Jhankris for much of their health care needs.6 However, these studies were mainly concentrated around the Kathmandu valley and major political and socio-economic changes have taken place in the past two decades. Many new medical colleges have come up all over Nepal and the number of trained doctors has increased substantially.7 Previously it was found that most local people preferred private dispensaries owned by so-called compounders to the free health services at the government operated health centres.8 Unfamiliarity with the medical personnel and absence of medicines were the reasons cited for not preferring the health centre. In Kaski district and other selected districts of Nepal a community fund has been set up to ensure that the health centres are well stocked with medicines. Self-treatment of common illnesses by lay people is common in economically deprived countries.9,10 Common reasons cited for self-medication are inaccessibility of health care facilities, economic constraints and previous experience of illness. Since drug-use studies in the community and factors influencing the drug use patterns are lacking in Pokhara valley the present study was carried out. Methods: The study was carried out in Pokhara sub-metropolitan city, western Nepal and the surrounding villages during the month of September 2001. The respondents were interviewed by the health workers of the department of community medicine who were briefed before hand. A semistructured questionnaire was used for the interviews. The ethnic group, occupation, average monthly family income, the number of members in the family and the address of the respondents were noted. The pattern of drug use in the families in the six month period preceding the date of data collection was noted. Details about the patient who had used medicines in the previous six months, the system of medicine preferred, the practitioner and the source of medicine was also collected. Details about the medicines, the patient outcome and the approximate expenditure on the medicines were noted. If relevant the reason for preferring complementary and alternative medicines(CAM) were also noted. Respondents were asked about any self-medication episodes

in their family during the preceding six months. The reason for not consulting a doctor and details of the medicines used for self-medication was collected. Differences in the proportion of patients using self-medication and complementary medicines according to age, place of residence and socio-economic status of family were analysed using the z test of proportions. A p value < 0.05 was taken as statistically significant. Results: One hundred and twelve respondents were interviewed using the questionnaire during the study period. Eighty seven of the 112 households surveyed (77.7 %) were male headed. The commonest ethnic group encountered in the study was Brahmins 34(30.3 %). Other significant groups were Gurungs 15 (13.4 %) and Chettris 13 (11.6%). Sixty one of the total of 112 households were engaged in non agricultural pursuits. Fifty two households were middle class by Nepalese standards with an average monthly income between 1000 and 3000 Nepalese rupees (13 and 40 US dollars). Twenty two households were poor with an average monthly income less than 1000 rupees (13 US dollars). Majority of the households (66.9 %) had less than 6 members. Eighty households were urban and the rest were rural. Seventy four households (66 %) had used prescribed medications during the study period. One hundred and twenty individuals had been prescribed medicines during the period. Forty three of the total of 120 individuals who had used medicines were aged between 20-30 years. The next commonest age group was between the years 40-50. The 120 respondents had a total of 164 encounters with the health care system in the 6 month period preceding the study. Modern allopathic medicines were prescribed in 118 encounters. The patients had visited more than one practitioner for an episode of illness. The doctor and the health assistant were the commonly visited practitioners and accounted for 28 % and 27.4 % of the total visits. Twenty eight % of the visits were to a CAM practitioner. The medical shop was the commonest source of medicines for the respondents of the study. The medical shops sold drugs both on prescription and also on demand from the respondents without a prescription. The medical shops generally sold allopathic medicines along with a few CAM remedies. In the 164 encounters a total of 217 drugs were prescribed giving an average of 1.32 drugs per encounter.

Traditional medicines constituted 32.2 % of the total drugs consumed. The commonest allopathic medicines consumed were antibiotics and paracetamol accounting for 24.3 % and 18 % of the total drugs prescribed. The approximate family expenditure on medications during the preceding six month period was less than 100 rupees (1.25 US dollars) in 32.9 % of the cases and more than 250 rupees (4 US dollars) in 34 % of the cases. Self-medication was practiced by 39 families of the 112 surveyed in the study. The commonest drug was paracetamol accounting for 41.3 % of the drugs used. Traditional home remedies accounted for 18.9 % of the drugs used for self-medication. The common sources of drugs used were the medical store and herbs and roots from the surrounding forests and also obtained from the courtyards of the houses. Among the 39 families who had taken self-medication and home remedies in the preceding 6 month period, 24 families had spent less than 75 Nepalese rupees (1 US dollar), 12 families had spent between 75 and 225 Nepalese rupees (1 and 3 US dollars) while 3 families had spent over 225 Nepalese rupees (3 US dollars). A significantly greater proportion of individuals above the age of 30 years had used complementary medicines compared to those less than or equal to 30 years of age (z=2.46, p<0.05). CAM usage was also significantly higher among families with an average monthly income less than 1000 rupees (13 US dollars). The commonest reasons cited for using CAM remedies were faith in the practitioner and less side effects. The reasons cited for the use of modern allopathic medicines from practitioners other than doctors were non-availability or decreased accessibility of doctors or the doctor was expensive. The reasons given for self-medication were simple illness, previous experience of treating a similar illness and medicinal herbs were easily available in the courtyard of the house. Discussion: The commonest ethnic group encountered in the study were Brahmins followed by Gurungs and Chettris. This corresponds to the data in the District development profile of Nepal.Most of the respondents in the study were engaged in non-agricultural occupations and this could be because 80 % of the respondents were residing in Pokhara city.

A total of 217 drugs were prescribed during the 6 month period which was studied. This is difficult to compare with previous studies as the population and socioeconomic parameters are different. 71.6 % of the respondents using medicines had used modern medicines. In a previous study based on the meta-analysis of literature more than 50 % of people in Nepal had used CAM remedies. The higher use of allopathic medicines could be due to our study population being more urban and the economic development indices of Kaski district being higher than of most other regions in Nepal. The respondents had visited more than one practitioner during an episode of illness. Common reasons cited were the illness was not cured, personal attention was not given by the practitioner and the patient did not have sufficient faith in the practitioner. The respondents preferred CAM remedies especially for chronic illnesses which is similar to the findings in previous studies.12,13 The doctor and the health assistant were the commonly visited practitioners. Doctors in private practice accounted for 60.2 % of the total visits to doctors. The utilisation of government health facilities was lower than that reported by previous studies in Ethiopia and Thailand. In a previous study in Nepal private practitioners were found to be more popular than the government health personnel The reasons cited for the preference were the private practitioners were local people and were more accessible at any time of the day or night. A proportion of the respondents had visited government doctors as private patients when they were doing private practice in the evenings. CAM remedies continue to be popular both as home remedies and on prescription by a CAM practitioner. Herbal remedies as shown in a previous study are easily available and in Nepal knowledge of herbal remedies precedes that of western medicines. CAM practitioners are usually village elders and occupy a high place in the society. Their position can be used to increase the acceptance of modern medical practices including immunisation among the rural population. There should be greater integration of modern and traditional medical systems which has been achieved to large extent in the far eastern Asian countries.17 The medical shop was the commonest source of medicines. Medical shops are common in both the urban and rural areas of Nepal and training of the drug retailers has been tried as an approach to improving the quality of medical care.18,19 The use of CAM remedies was significantly higher among persons above the

age of 30 years and among families of low socioeconomic status. The use was also significantly higher among rural households. So economic criteria, lack of accessibility to modern health care systems and easy availability of herbal remedies were the common factors predisposing to the use of CAM remedies in Nepal. Self-treatment and home remedies are a common and often necessary part of health care. The reasons commonly cited for self-medication were easy availability of herbs, previous experience of treating a similar illness and economic constraints. These were similar to the reasons cited in previous studies.11,19 Thirty nine families surveyed had used self-medication which is similar to reports in the literature.15,21 Analgesics were the commonest drugs used for self-medication. Selfmedication was more common among rural households (z=3.2, p<0.05) compared to urban ones. Drug hoarding has been reported in the literature 14 and distance is an important factor influencing the utilisation of health services.8 Because of the difficulty in reaching health care services and because the medical shops are widely distributed in the villages the rural population may be more prone for self-medication practices. Increased accessibility to medicines, improvement of the government health care system and a greater integration of traditional and modern health systems will help to improve the health status of the population. Further studies to assess drug use patterns and health care needs of the population are urgently required. References: 1. Gartoulla RP. Alternative medication practices (dissertation). Darjeeling( India). Centre for Himalayan Studies, North Bengal University, 1992. 2. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA project. J Int Med 2001;250(3):225-33. 3. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA et al. Long term trends in the use of complementary and alternative medical therapies in the United States. Ann Int Med 2001;250(3):262-8.

4. Mitzdorf U, Beck K, Horton-Hausknecht J, Weidenhammer W, Kindermann A, Takaes M et al. Why do patients seek treatment in hospitals of complementary medicine. J Altern Complement Med 1999;5(5):463-73. 5. Furnham A, Kirkcaldy B. The health beliefs and behaviours of orthodox and complementary medicine clients. Br J Clin Psychol 1996;35:49-61. 6. Shrestha R, Lediard M. Faith-healers: A force for change. UNICEF, Kathmandu, 1980. 7. Sharma HB, Gautam RP, Vaidya S. (Eds.) District development profile of Nepal. Informal sector research and study center, Kathmandu, 2001. 8. Dhungel B. Accessibility to social services in rural Nepal: a case study in Kavre district (dissertation). Bangkok. Asian institute of technology, 1983. 9. Chaulagai CN. Community financing for essential drugs in Nepal. World Health Forum 1995;16(1):92-4. Table 1: Sources of medicine sought by the respondents during health encounters No. of encounters Source Medical shop Health post Traditional practitioners Home remedies Hospital Total 61 41 32 24 6 164

Table 2: Number of visits to a complementary medicine practitioner according to the age of the patients

Age of patient

 30 years System of medicine Modern Complementary Total 66 16 82

>30 years Total

52 30 82

118 46 164+

z value = 2.46, p<0.05 + The 120 persons who had been prescribed medicines in the 6 month period under evaluation had made multiple visits to the practitioners Table 3: Complementary medicine use according to the socioeconomic status of the family System of medicine Average monthly income (Rs.) <1000 1000-3000 >3000 Total Modern 17 58 43 118 Complementary 19 , 12 15 46

Total

36 70 58 164+

z = 2.7, p<0.05 compared to the group with average monthly income greater than 3000 z =4, p<0.05 compared to the group with average monthly income between 1000 and 3000 + The 120 persons who had been prescribed medicines in the 6 month period under evaluation had made multiple visits to the practitioners . Table 4: Rural-urban differences in the frequency of self-medication

Self-medication Place of residence Urban Rural Total z value =4.55, p<0.05 Used 15 24 39 Not used 58 15 76

Total

73 39 112

REVIEW
In Nepal, traditional health care providers have an important role to play in the provision of health services. Non-doctor prescribing of allopathic medicines is commonly carried out by compounders, health assistants and other practitioners. Self-treatment in which herbal remedies play a large role is also common. Most of the previous studies have been carried out in the Kathmandu valley. As studies in the Pokhara valley are lacking the present study was carried out. Methods: The study was carried out in Pokhara sub-metropolitan city and the surrounding villages in the month of September 2001 using a semi-structured questionnaire by the health workers of the community medicine department. The pattern of drug use in the preceding 6 month period was noted. The doctor and the health assistant were the commonly visited practitioners. Doctors in private practice accounted for 60.2 % of the total visits to doctors. The utilisation of government health facilities was lower than that reported by previous studies in Ethiopia and Thailand. In a previous study in Nepal private practitioners were found to be more popular than the government health personnel The reasons cited for the preference were the private practitioners were local people and were more accessible at any time of the day or night. A proportion of the respondents had visited government doctors as private patients when they were doing private practice in the evenings. CAM remedies continue to be popular both as home remedies and on prescription by a CAM practitioner. Herbal remedies as shown in a previous study are easily available and in Nepal knowledge of herbal remedies precedes that of western medicines. CAM practitioners are usually village elders and occupy a high place in the society. Their position can be used to increase the

acceptance of modern medical practices including immunisation among the rural population. There should be greater integration of modern and traditional medical systems which has been achieved to large extent in the far eastern Asian countries. The medical shop was the commonest source of medicines. Medical shops are common in both the urban and rural areas of Nepal and training of the drug retailers has been tried as an approach to medical care. 2.REVIEW OF LITERATURE: ALLOPATHIC V/S AYURVEDA PRACTISES IN

TERTIARY CARE INSTITUTE URBAN NORTH INDIA. (THIS RESEARCH PAPER IS ATTACHED ALONG WITH THIS FILE PLEASE SEE ADOBE READER FILE )

REVIEW
This study clearly indicated the popularity of cross-pathy practises among both qualified allopathic and ayurvedic practitioners. However, clause 1.13 of medical council of India prohibits the allopathic practitioners from allopathic system of medicine. Hence, there is urgent need to undertake educational and reorientation programmes of registered medical practitioner regarding various MCI rules and regulations. Even the ayurvedic practitioners need to be adequately trained to recognize conditions that require referrals to allopathic practitioner. Moreover large scale epidemiology studies should be conducted both in the urban and rural part of the country, comparing the trend of cross-pathy practises among qualified practitioner of the both system of medicines as well as comparing the trend of CAM and allopathic drugs use as self medication between different sections of the society . Nonetheless, high quality, clinical trails are required to establish the safety and efficacy of ayurvedic drugs . The benefit of the patient lies in the optimal balance and evidence based use of the two systems and this needs to be encouraged especially in developing countries like INDIA with inadequate doctor patient ratio.

CHAPTER-2
INTRODUCTION OF COMPANY

BRIEF PROFILE OF IND SWIFT GROUP Ind Swift Group, a legendary forename in the world Class Pharmaceutical Industry who has broaden its horizons by plucking profound & sparkling footprints on multifarious diversified fronts, whilst going steadily and surely, scripting a success story filled with enviable milestones and pioneering breakthroughs and has subsequently emergent as a group with an annual turn over of 1600 Crore. ORGANISATIONAL STRUCTURE-IND SWIFT GROUP Ind Swift group, as pharmaceutical business model is one of India's largest manufacturer of high growth multi segment pharmaceutical finished dosage forms and API's (Active Pharmaceutical Ingredients). Manufacturing of Pharmaceutical finished dosage are carried out at 7 state-of-the art manufacturing facilities which are second to the none are duly certified and approved by WHO GMP, spread over an area of 12, 00, 000 sq. ft. with manufacturing capacities confirming to stringent TGA/MHRA approvals; possessing an installed capacities of 3 billion units comprising tablets, capsules, Ointments, Injectable, Liquids & Dry Syrup (all latest formulations with a marketing network. API section has spread over an area of 7 Lac sq. ft, carried out at 3 different state-of-the-art units approved by USFDA and E.U regulatory authorities with a marketing network spread over in 40 countries viz. Europe/USA/Middle East possessing 2 patented molecules with 11 molecules in offing It possesses 50% exports percentage. Ind Swift entered into bulk drugs with its own Research and Development facility and laboratories at Derabassi. Later on, those units got USFDA approval and got the process patents for Clarithromycin for US and allied markets and further five more patent drugs await clearance for the moment. A joint venture with Iran has also been signed for the manufacturing of Clarithormycin with construction underway and will start operations by the end 2008. The company has offices and supplies pharma drugs not only in India but overseas as well.

R & D (Research & Development)

Ind Swift is known for it's reverse engineering ability with highly focused R & D capabilities (duly approved by Department of Science & Technology, Govt. of India) and is equipped with state-of-the-art equipment, facilities and talented pool of scientists and Researchers. A well accepted expertise in NDDS, in India and the world over. A US patent for Clarie OD, with a market size of US$ 300 million. Another patent for Fexofenadine ODT with a market size of US$ 2.5 billion. Development of 10 new molecules with a market size of US$ 6 billion. Ind Swift's efforts and achievements in taste masking of macrolides was India's first......... and remains the only feat of its kind in the country. The R &D department is also involved in creating international opportunities and alliances for CRAMS business, contributing significantly to the Company's profitability. It also offers complete support to international partners for preparing and filing dossiers for finished dosages. By taking giant strides on roads less traveled, Ind-Swift has become one of India's fastest growing pharmaceutical companies.

R & D's Achievement

Its pioneering R & D efforts have led to the creation and introduction of blockbuster drugs like: Atrovastatin One of the most effective cholesterol lowering drugs with an estimated market size of US$ 12 billion. Nitazoxanide a wonder, one of its kind anti-diarrheal with a market of US$ 6 billion. Pioglitazone an anti-diabetic drug ranked among the first five in its Therapeutic segment. Arthrill an herbal wonder for the treatment of Arthritis. Anaproct an ayurvedic product providing relief from piles within 24 hours with no allopathic cometitor. Ind-Swift has strategic R&D and manufacturing alliances with companies in the United Kingdom, Turkey and Iran. In formulations front, Ind Swift proud of its multifarious achievements viz. Neurophen forte, a composition of Ibuprofen & Acetamenofen. Ind Swift is the company to give this composition to the country for the first time. Another formulation i.e. Suprox SR, a composition of Isoxprine

Hel, sustained release tablets was first time launched in India in tablet form. Mouth dissolving tablets technology was introduced for the first time in India by Ind Swift. The company today stands second in the north in pharmaceutical sector. It is an honour to add here that we are among the top 500 fortune companies of India and have been ranked at No. 35 by IMS/ORG in Pharmaceutical industry & possess a portfolio of 650 products with presence in high growth therapeutic segments of Cardiology, Diabetology, Anti depressant, anti-allergic, Anti- infective, Neurology & Oncology with a nation wide distribution network comprising 1200 marketing professional working with 12 marketing divisions, 50 offices in India, 3000 super stockists and stockists.

Sparkling footsteps on diversification front are as under mentioned:Infrastructures: Ind Swift has radianced up in infrastructures business in the name and style of Ind Swift Infrastructures and developers Ltd, and has come up with a multi crore project named Regalia Towers, of course a society with 2 bedroom /3 bedroom flats and penthouses owing a mystique which is exemplary in itself which not only reflects a diversified transformative spell to infrastructures front but a unique state of art with the best of specifications also. In infrastructures, Ind Swift plans to be emergent with motels & Resorts project in the upcoming phases.

Publishing & Packagings:

Ind Swift by virtue of its strong business acumen has also put a step in the field of publications also in the name and style of Mansa Print & Publishers Ltd's which has hovered over the industry within a very short span by coming up with Aluminum Division in 2007 wherein the manufacturing & printing of various type of packaging material viz. Aluminium collapsible tubes, mono cartons etc is undertaken and now will add a new feather in ISL's cap by launching a separate unit for PE, Lami tubes and PET bottles. Not only this it further proposes to come up with a stationary unit for which the building has already been constructed. The total plan will increase Mansa's sale by 200%. Another project for Injunction moulding has also been proposed. Both these plants have a total layout plan out of Rs. 40 crore.

Media & Publication:

Ind Swift has focused up in media & publication sector under the name Ind Swift Communications Pvt. Ltd with its illustrious and infomercial journals as Pharmabuzz, Trendz, ADI (Drug Index), Agrovet and further proposes to come up with General magazines

and tabloids.

Software Development:
Ind Swift has also entered into IT & software with their initial projects of developing web portals, search engines optimizations, website development, software & ERP systems development. Its initial portals which are already on air are OTC mart.com, buysweethome.com, painting &photographs.com, doctorsonline.com & ayurvedaherbs.com.

Sparkling footsteps on diversification in Education front are undermentioned:Swift Institute:Our Swift Institute is exclusively diverse from the plenteous private educational institutions cropping up in North India, having world class infrastructure, faculty, laboratories and other facilities. To initiate with, we have instituted six months Industrial Training Courses in Pharmaceutical Sciences, for Operator Level Training which has enabled the 10th or 10+2 students to start a career in the booming Pharma industry & until now we have already trained and placed more than 400 students at Ind Swift which we feel contributes a lot to the skilled manpower starving industry. Swift Fundamental Research Education : SFRE (Swift Fundamental Research Education ) is a society made under the banner of Ind Swift which has recently laid an another step on the diversification spree and has forayed up with a Pharmacy college at Rajpura with the name & style of Swift School of Pharmacy, and is a unique state of art with the best of specifications also. With this new venture of IND SWIFT, we have been ranked as the pioneers in this part of the country having a solid pharmaceutical industrial background to come up with our own

Pharmacy & Nursing institute. The institute will be operational from current session year 20082009 with an intake of 60 students in the field of Pharmacy and Nursing each, in the first year by virtue of its high resourcefulness and know-how and will provide quality education to one and all, aspiring careers in the field of Pharmacy. We manifest to be imminent with Engineering, Architecture, Management, Hotel Management, General Management, Schools of Dentistry, Ayurveda Physiotherapy and Medical Technology and finally a Medical College with its functioning operational by 2010-11 under the budget of Rs. 250 Crore with a specific target on Medical Tourism. Domestic Marketing: The company's new division diagnosis dealing in medical equipments & devices thereby focusing personal health care was launched in December 2007 and has reflected promising performance & is growing leaps and bounds from the first month of its launch which has given utmost confidence to the company to get the aggrandized sales and contribution not in the current year but in the forthcoming years as well. Not only this, the division projects to achieve a business objective of 10 crores with impressive contribution to ISL and possesses a strategy of adding up few other specialty products in the existing range of personal health care & Academic Body model series. Another division launched by your company is Animal Health Care which is an absolutely new concept with outsourced marketing and has proved out to be an individual profit center. Apart from struggling uphill for the current range of products our Ethical marketing have introduced those products during the year which are monopolistic in nature viz. Cirrholiv which has proved out to be a remedy in Hepatitis and other liver disorders. Other brands introduced by your company during the year are Topclav 625, Emtee 25 and Timcol Eye Drops. In Generics, your company emerged as the 2nd rank Pharma Generic company and has attained the fame of featuring its few brands (Amyclox, Swimox, Oxo, Swiflox and Cafzone (already achieving the sales growth over 25 crore) as the top brands in Generics. Company's brand Swimox has been enlisted among leading brands in ORG IMS and Amyclox leads the que among top 300 brands of the industry. Annual growth for the company during the year is 36.73%.

RESEARCH & DEVELOPMENT

Looking at the current scenario where the pharmaceutical majors are engaged in the advancement of R & D, we have been competent enough to work out on non infringing processes, Novel Drug Delivery Systems, dossiers, stability data profiling, conceptualization of new molecules (and therefore a nmber of product combination have been developed and are ready to be launched by our marketing divisions). Your company's R&D is involved in creating international opportunities and alliances for CRAMS (specially contract Research) to make it contribute 30% of profits. Till date two major contracts were signed an have been delivered. We are hopeful to attain more contracts on product development and stability data profiling. Apart from this, we are applying invincible efforts to get approvals for a Bio-equivalence centre which will further strengthen the basket of R&D. To strengthen the CRAMS business to the exquisite level, your company is tying up with various academic institutes. By virtue of the hard endeavors of R&D all through the year, unique combinations/NDDS of single molecule are around the corner and awaiting launch by this year. Apart from this, R&D is emphasizing on a major area which is cost Reduction. More than 5% of total revenues have been planned to spend on the company's R&D and the same will be continued in the forthcoming years as well. Units of IndSwift: IndSwift has two units in PARWANOO and two in BADDI.

Mission:

Vision:

Ind Swift Ltd. Moving towards INR - 1000Cr. by 2010

Values
1.Consistent Profitable Performance 2. Commitment to maximize the wealth of our shareholders and catering to the interests of our customers and employees. 3. Innovation to Nurture Good Partnerships with Customers 4. Develop therapies and processes and provide services of the highest value to nurture good partnerships with customers 5. Responsibility towards Environment, Safety and Health 6.Nurturing the undying spirit for researching active substances to combat disease, protect the environments we inhabit, and the Society we serve. 7.Commitment to the Highest Standards of Ethics & Integrity 8.Actions in accordance with words and values. Respecting the laws in business ethics of the countries in which we operate. 9.Valuing the Ability to Excel, Integrity, Knowledge, Skill, Diversity and Team work of Employees 10.Treat everyone fairly and with respect to create an environment of Mutual respect, encouragement and teamwork.

Future and history:

In todays world of rapid change, future shock is no longer shocking. To those who do not plan for future, future may come too soon. But to those with careful preparation and accurate anticipation, to those with vision, future is where we are going to prosper. Towards which desirable end, we endeavour today. With promising molecules in our manufacturing pipeline, we are going to meet our future with great preparation and nonchalance.

For details visit our group companys website Indswift Labs Limited. To develop various types of NDDS for selected therapeutic segments. 12 new drug / combination being developed under NDDS to be introduced first time in India. Contract research Contract manufacturing Joint ventures in marketing finished dosage forms in India, SAARC and South East Asian countries. - Dedicated to be an integrated healthcare company: - Chain of Multi -specialty hospitals - Pharmacy chain - Chain of diagnostic laboratories CHRONICLE: 2007-2008 Company has achieved the 35th rank among top 300 pharma industries in 2007-08 Company has got international approvals viz. MHRA(UK),TGA(Australia),WHO(Geneva) and other such regularly bodies. We achieved MoH(UAE),TFDA(Tanzania),NDA(Uganda) and DACA(Ethiopia). The company's new division Diagnozis dealing in medical equipments and devices was launched in December 2007. Animal Health Care is another division launched by our company which is absolutely new concept with outsourced marketing. Ethical marketing Division of the company introduced products during the year viz. Cirrholiv useful in curing Hepatities and other liver disorders. In Generics,company merged as the 2nd rank Pharma Generic Company New brands in Generic are Amyclox,Swimox,Oxo,Swiflox and Cafzone achieving the sales growth over 25 crore. Company's manufacturing unit at Parwanoo has also been upgraded as per WHO standards. Company's Global Business unit (GBU) at Derabassi has got MHRA & TGA approval. Manufacturing unit at Baddi(H.P.) received WHO GMP certification for tablet/SVP/Liquid manufacturing. 2006-2007

Company has entered in an advanced stage of Launching its products in the International Markets. The Company's 100% Export Oriented Global Business Unit,(GBU) is complaint to the GMP specifications of MHRA(UK),TGA(Australia) and other regulatory bodies. Company also launched its product in Kenya and Senegal. The Company has filled more than 100 dossiers for registration in about 20 countries around the world stretching from South America to Philippines. The third new division is Agile which has been launched in joint venture with a Dubai based Pharma company focusing on Pain Management & Anti-infectives. The Company introduced various new product ranges in the domestic markets through its 12 marketing divisions,a total of 40 offices in India,3000 stockists & superstockists across the country with an enhanced field force of 1400 marketing professionals endeavoring hard in broaden therapeutic segments of Cardiology,Diabetology,Neurology and Oncology. Company has been ranked 41st among top 50 leading pharmaceutical giants. Company R&D with available scientific pool of 100 scientists working on different projects on dossiers,DMFS in CTD formats,stability data profile,conceptualization of new molecules,planning for bioequivalence and clinicals. More than 5% of total revenues have been planned to spend on the company's R&D . Company's another feather in its cap is its new manufacturing facility for soft gelatin encapsulation with an annual capacity of 35 Crore Soft gelatin Capsules, which will be put into operation during current financial year. 2004-2005 Launched combination of Nitazoxanide and Ofloxacin, with the brand name Netazox-OF, first time in Asia. Ind Swift Group achieved a turnover of 480 crores. 2004 Launched Mukur Division with focus on ophthalmology, neuropsychiatry and ENT. Another division launched by the name Resurgence catering to the Anesthesiology and Oncology segments. Ind-Swift group achieved a turnover of INR 375 Crores. Launched Nitazoxanide, an antidiarrhoeal drug, first time in India after successful clinical trials.

Got DGQA registration Opened first overseas office in New Jersey, USA 2003 Ind-Swift group achieved a turnover of INR 300 Crores Launched another division by the name Ind-Swift Biosciences. Ind-Swift enters into formulations export to 6 countries. Filed Patent in US for Clarithromycin 2002 Bagged ISO 9001-2000 Certification. Attained leading position in the world in the products like Clarithromycin granules Exports to almost 40 countries in the world and set up eleven representative offices worldwide. 2001 Launch of Institution/Hospital Division. 2nd Company to launch Pioglitazone and Candesartan in India 2000 Launched Super Specialty Division (SSD) focusing on Cardiology and Diabetology segments. 1997 A 30 crore multipurpose plant commissioned with five independent blocks erected as per cGMP and US FDA standards, designed by Quara, Switzerland. Another Marketing Division launched with the name Ind-Swift Health Care. 1996 Ind-Swift floated Ind-Swift Laboratories Limited in 1995 to initiate a backward integration into the manufacturing of APIs and advanced intermediates. 1994 Ind-Swift went public with issues oversubscribed 52 times 1991 Set up a manufacturing facility for injectables and eye/ear drops. 1986 Birth of Ind-Swift limited. Introduced for the first time in India sustained release tablet of Isoxsuprine HCL 1983

Year of Foundation

MARKETING:

1000 professionals in different divisions market finished dosage forms throughout the Over 40 offices in India Eleven representative Offices worldwide. Strong doctors base of over 2.5 lakh doctors of various specialties. Strong retailer coverage base of over 3 lakh retailers. Stockists base of over 3000 all over India

country.

MANUFACTURING:

All the manufacturing units are designed to comply with current GMP norms as proposed

by stringest world regulatory bodies like USFDA, MHRA, EU, and WHO, and accreditations from ISO 14000 Ind-Swift is known as one of the biggest global bulk producers of APIs like clarithromycin, fexofenadine, atorvastatin etc. (For details visit our group companys website Ind-Swift Labs Limited.) trials Launched combination of Nitazoxanide and Ofloxacin, with the brand name Netazox-OF, Launched Nitazoxanide, an antidiarrhoeal drug, first time in India after successful clinical first time in Asia

QUICK FINANCIAL SYNOPSIS:

BRIEF: For the fiscal year ended 31 March 2009, IND Swift Ltd's revenues increased 14% to RS5.92B. Net income increased 1% to RS314.5M. Revenues reflect an increase in income from operations. Net income was partially offset by an increase in consumption of raw materials, higher purchase of traded goods, an increase in employee cost, higher depreciation & amortisation expenses and lower other income. Price Performance Period 4 Week 13 Week 26 Week 52 Week YTD Price History Period 12 Month High 12 Month Low Current P/E
Balance sheet
Mar ' 08 Mar ' 07 Mar ' 06 Mar ' 05 Mar ' 04

Actual (%) 4.90 32.49 61.64 -13.77 53.93 Value 26.80 10.50 2.41

Sources of funds
Owner's fund

Mar ' 08 Equity share capital Share application money Preference share capital Reserves & surplus 7.44 0.16 170.62

Mar ' 07 7.44 0.16 141.17

Mar ' 06 7.44 2.95 119.34

Mar ' 05 7.28 3.10 102.52

Mar ' 04 4.63 6.04 65.74

Loan funds
Secured loans Unsecured loans Total 308.91 83.00 570.12 227.50 74.80 451.07 153.09 40.58 323.39 90.36 27.08 230.33 49.63 18.02 144.06

Uses of funds
Fixed assets Gross block Less : revaluation reserve Less : accumulated depreciation Net block Capital work-in-progress Investments 159.34 18.12 141.22 97.49 28.30 96.99 12.07 84.92 98.75 18.76 50.80 8.28 42.52 88.85 15.39 32.23 6.20 26.03 22.88 18.67 23.90 4.88 19.02 4.70 14.75

Net current assets

Current assets, loans & advances Less : current liabilities & provisions Total net current assets Miscellaneous expenses not written Total 425.04 147.18 277.86 25.25 570.12 330.58 106.94 223.65 24.99 451.07 218.45 60.33 158.12 18.51 323.39 192.76 41.22 151.54 11.22 230.33 137.36 37.54 99.82 5.76 144.06

Notes:
Book value of unquoted investments Market value of quoted investments Contingent liabilities Number of equity sharesoutstanding (Lacs) 5.39 19.38 371.78 371.78 5.27 52.54 43.87 371.78 4.61 87.90 54.50 72.76 2.08 83.42 46.25

Market Capitalisation Market Cap (Rs Millions) Shares Outstanding Float Per Share Data (Rs INR) Earnings Sales 8.45 159.26 756.58 37.18 23.50

Book Value Cash Flow Cash Valuation Ratios Price/Earnings Price/Sales Price/Book Price/Cash Flow Return on Equity Return on Assets Return on Investment

----

2.41 0.13 -1.86 ---26.40 6.68 5.31 -------

Management Effectiveness (%)

Profitability Ratios (%) Gross Margin Operating Margin Net Profit Margin Dividend Information Dividend Yield (%) Payout Ratio Financial Strength Quick Ratio Current Ratio LT Debt/Equity Total Debt/Equity Dividend Per Share (Rs INR) 0.0

Chart for indswift(stock exchange)

PRODUCT RANGE AND LAUNCH:

Product Netazox Clarie OD Glitter Candez Atstat UT Guard Fexidine Excef Clarie DT Clarie Suprox SR Anin

Therapeutic Anti diarrhea Macrolide Anti diabetic

Position at the time of launch in India 1st 2nd 5th 2nd 4th 2nd 3rd 3rd 1st 2nd 2nd 2nd

Year ofLaunch 2004 2003 2001 2001 2000 2000 2000 1999 1999 1998 1987 1985

Cadiovascular Cardiovascular Vasodilator Anti histamine Antibiotic Macrolide Macrolide Vasodilator Allyoestrenol

Product Range of the Ethical Division of Ind - Swift INJ ANIN-250 INJ ANIN-500

INJ DECANEUROPHEN-25 INJ DECANEUROPHEN-50 INJ NEUROPHEN-25 INJ UTGARD(5 ML) INJ. UTGARD (1 ML) INJ. VORANIN-100 INJ. VORANIN-200 INJ INORINE 2 ML TAB ANIN TAB CLARIE - 250 TAB CLARIE - OD TAB CLARIE DT TAB COZY PLUS TAB ETOXIN - B TAB NEUROSPAS CD TAB SUPROX TAB SUPROX SR TAB STEMIN TAB STEMIN FORTE TAB. INDAXIN -B6 TAB. INDCEF-DT TAB. INDCEF-100 TAB. INDCEF-200 TAB. UTGARD TAB GLUFIT-15 TAB GLUFIT-30 TAB.MENOGUARD TAB.NEUROSPAS-MF TAB TOPCLAV-625 TOPCLAV D/SYRUP TAB TOPCLAV-375

TAB INORINE TAB INORINE-M TAB TERPREG 200 MG TAB EMTEE TAB ERGEST - LD TAB ERGEST TAB FERTILIN-50 TAB MEDANIN-10 MG TAB CALSTAT TAB CALSTAT-DS TAB OFREE CAP NEUROPHEN FORTE CAP NEUROSPAS CAP DISTONE CAP BENPROST-8 CAP VORANIN-100 CAP. VORANIN-200 CAP MUBEXIN CAP. ANAPROCT CAP INDILAC CAP. CIRRHOLIV CAP CALSTAT-BD CAP PM CARE COZY KID ETOXIN-B EXPECTORANT PHENA KID PHENA P OLIADE BATH OIL COZY COOL DROPS NEUROSPAS-DROPS DISTONE SYRUP

CALSTAT-SUSP UTININ SYP STEMIN-GM STEMIN-MF ANAPROCT OINTMENT MUBEXIN ZINC DROPS INDCEF-LB DRY SYRUP GDSAFE DRY SYRUP GDSAFE-DS DRY SYRUP SYP. AMBICET INDILAC SACHET

Ayurvedic products:

Proven Ayurvedic remedy for cardiovascular ailments Helps in maintaining optimal blood pressure Lowers blood cholestrol Useful aid for liver ailments

Helps in controlling DIABETES Mellitus Helps maintaining appropriate Blood Sugar Level Important in Comprehensive Diabetic Care

Works as Anti Stress (Adaptogen) Works as Anti Oxidant Restores and enhances Physical & Mental Endurence Useful in Respiratory system ailments

Improves quality of semen Improves Sperm Count and motility. Effective in Impotency Improves nourishment to body tissues Promotes urinary flow

Optimize Gastrointestinal Function Natural and gentle Laxative useful in constipation Effective in Heartburn and stomach upset Useful in Chronic Diarrhoea and Piles Combines well with Amalakiy

As Lipid Regulator, Alters Lipid Metabolism Promotes good cholestrol Lowers bad cholestrol Lowers triglyceride and Effective in maintaining healthy Cardiovascular system.

Excellent Blood Purifying properties Natural aid for Skin diseases Bitter taste helps in worm infestations and viral infection Effective in Diabetic care

Board and directors and staff:

Mr. S. R. Mehta Mr. N.R.Munjal Dr. G. Munjal Dr. V. R. Mehta Mr. Himanshu Jain Mr. V. K. Mehta Mrs. Nirmal Agarwal Mr. K.M.S.Nambiar Dr. N.D.Aggarwal Dr. R.S.Bedi Dr. H.P.S.Chawla Dr. S.K.Mathur Mr. N.K.Bansal Mr. Amit Tarafder Mr. R.K.Sood Mr. O.P.Thapliyal Mr. Gaurav Aggarwal Mr.Anurag Kastwar Mr.J.S. Saini Chairman Vice Chairman Managing Director & CEO Jt.Managing Director Executive Director Director Director Director Director Director Director Director Group Head(Finance) Vice President(Finance) Company Secretary vice president (HR) vice president (commercial) vice president (marketing) senior manager( marketing)

CHAPTER- 3

OBJECTIVE OF THE STUDY:

1> To assess the usage of allopathic or ayurveda system by the doctors. 2> To study the preferences of the systems by the doctors taking the reasons as side effects, time duration , safety. 3> To study the availability the medicines in clinic or nearby retailers . 4> To know diversifying allopathic to ayurveda by industries is right step or not. 5> To study the order of preferences by the doctors towards the different medical professionals. SCOPE OF THE STUDY: The scope of study means the subject matter to be researched in the study . it defines the overall rationale of the study by explaining the geographically area of the study along with type of the data. In order to accomplish the objectives of the project . survey conducted in himachal Pradesh and Chandigarh to fill the questionnaire by the doctors which designed for the purpose of the survey . on the basis of data collected I analysis the result of the project .

RESEARCH METHODOLOGY

In order to gets information by various reasons the research methodology is as follows: DATA COLLECTION: Adequate and authentic data is the foundation stone for an analysis. It is very necessary that the data should be adequate and relevant so that the analysis which we derive from that data is exact. So data collection requires due attention and care. In order to get the required basic information about the usage of medical system by doctors and for what disease . I relied on both primary data and secondary data. PRIMARY DATA:

Regular visit to the organization i.e.IndSwift Ltd. In Chandigarh and after regular visit to market and meetings with doctors was made to obtain the required information and learn about the market and organisation how it works. Interviews with the management officials and staff of the organization to get latest information. SECONDARY DATA: Books, Magazines, Articles from internet etc. constitute the secondary sources of information for the project report. SAMPLING PLAN: Universe : The population of study consists of hamirpur and chandigarh. Sample Size : Sample Sizes 40 respondants. 20 doctors of ayurveda and 20 from allopathic . Sampling Technique : I have used technique of convenience sampling. Geographical scope: hamirpur (h.p) and chandigarh . . Tool for data analysis : Percentage method for getting results. doctors and retailers (pharmacy shops) I

AN OUTCOME OF RESEARCH METHODOLOGY

Collection of Information from IndSwift.

Taking permission from guide.

Getting questionnaire filled from people

Analysis of information

Interpretation of data

Suggestion and Recommendations

CHAPTER-4
Evaluation study to assess the usage of Allopathic and ayurvedic system BY doctors (VIEWS OF AYURVEDA DOCTORS) NAME: QUALIFICATION DATE : ..................................... Q.NO: 1: DO YOU USE ALLOPATHIC PRODUCTS? a. YES b. C. NO AT TIMES

Q.NO:2: NAME OF THE DISEASE FOR WHICH YOU PREFER ALLOPATHIC TREATMENT a. GIT b. LIVER DISORDER c. HEART DISEASE d. CANCER e. ANY OTHER (PLEASE SPECIFY). .

NO RESULT % 20 Q.NO:3: (A) DOES PATIENT OVERALL SATISFIED WITH ALLOPATHIC PRESCRIPTION AND MEDICINE GIVEN BY YOU? a. YES b. NO

(B) IF NO, WHAT IS THE COMPLIANCE OF PATIENT FOR ACCEPTANCE OF ALLOPATHIC TREATMENT .. .

NO RESULT % 20 Q.NO:4: YOUR PREFRENCE TO ALLOPATHY IS THEIR SHORT DURATION OF TREATMENT AS COMPARE TO AYURVEDIC a. STRONGLY AGREE b. AGREE c. NEUTRAL d. DISAGREE e. STRONGLY DISAGREE

NO RESULT % 20 Q.NO:5: (A) WHETHER MEDICINES ARE GENERALLY AVAILABLE WITH NEAR BY RETAILERS a. YES b. NO

(B) IF NO, WHAT IS REASONS FOR NON PROVIDING MEDICINES TO PATIENTS ........................................................................................................................................

. NO RESULT % 20 Q.NO:6: DO YOU BELIEVE IN COMBINATION THERAPY (ALLOPATHY WITH AYURVEDA) ? a. YES b.NO c. AT TIMES

NO RESULT % 5 Q.NO:7: WHAT IS THE TIME DURATION YOU PREFER FOR ALLOPATHIC TREATMENT? a. 3 DAYS b.3-5 DAYS c. A WEEK d.MORE THAN A WEEK

Q.NO:8: IN NEW ERA OF MEDICINE, COMPANIES ARE DIVERSIFYING FROM ALLOPATHIC PRODUCTS TO AYURVEDA. DO YOU THINK THIS IS THE RIGHT STEP? a. YES b. NO PLEASE COMMENT ON YOUR ANSWER .

Q.NO:9: DO THE PATIENT SHOWS THEIR PREFERENCE TO ALLOPATHIC SYSTEM a. YES b. NO

Q.NO: 10: WHAT IS YOUR ORDER OF PREFERENCES IN RESPECT OF VARIOUS SYSTEMS OF MEDICINES LIKE HOMEOPATHIC , ALLOPATHIC , AYURVEDA , UNANI. a. 1ST b. 2ND .. c. 3RD . d. 4TH 85% GIVE 1ST RANK TO AUYURVEDA 15% GIVE 1ST RANK TO ALLOPATHIC

Evaluation study to assess the usage of Allopathic and ayurvedic system BY doctors (VIEWS OF ALLOPATHY DOCTORS) NAME: DATE :..................................... QUALIFICATION:

Q.NO: 1: DO YOU USE AYURVEDIC PRODUCTS? a.YES b.NO c.AT TIMES

Q.NO:2: NAME OF THE DISEASE FOR WHICH YOU PREFER AYURVEDIC TREATMENT a. GIT

b.LIVER DISORDER c.HEART DISEASE d.CANCER

e.ANY OTHER (PLEASE SPECIFY). .

Q.NO:3: (A) DOES PATIENT OVERALL SATISFIED WITH AYURVEDIC PRESCRIPTION AND MEDICINE GIVEN BY YOU? a. YES b. NO (B) IF NO, WHAT IS THE COMPLIANCE OF PATIENT FOR ACCEPTANCE OF AYURVEDIC .. .

Q.NO:4: THE REASONS FOR PREFERENCE OF AYURVEDIC MEDICINE, IS THEIR SAFETY AND NO SIDE EFFECTS . a. STRONGLY AGREEE b.AGREE c.NEUTRAL

d.DISAGREE e. STRONGLY DISAGREE

Q.NO:5: (A) WHETHER MEDICINES ARE GENERALLY AVAILABLE WITH NEAR BY RETAILERS a. YES b. NO (B) IF NO, WHAT IS REASONS FOR NON PROVIDING MEDICINES TO PATIENTS

. Q.NO:6: DO YOU BELIEVE IN COMBINATION THERAPY (ALLOPATHY WITH AYURVEDA) ? a. YES b.NO c.AT TIMES

Q.NO:7: WHAT IS THE TIME DURATION YOU PREFER FOR AYURVEDIC TREATMENT? a. A WEEK b.A MONTH c.SIX MONTHS d. MORE THAN SIX MONTHS

Q.NO:8: IN NEW ERA OF MEDICINE, COMPANIES ARE DIVERSIFYING FROM ALLOPATHIC PRODUCTS TO AYURVEDA. DO YOU THINK THIS IS THE RIGHT STEP? a. YES b. NO PLEASE COMMENT ON YOUR ANSWER

Q.NO:9: DO THE PATIENT SHOWS THEIR PREFERENCE TO AYURVEDIC SYSTEM? a. YES b. NO

Q.NO: 10: WHT IS YOUR ORDER OF PREFERENCES IN RESPECT OF VARIOUS SYSTEMS OF MEDICINES LIKE HOMEOPATHIC , ALLOPATHIC , AYURVEDA , UNANI. a. 1ST b.2ND .. c.3RD . d. 4TH 90% says allopathic 10% says ayurveda.

CHAPTER-5 SUMMARY
This study is based on the usage of two medical system by the different doctors . in this whole project the result was carried out by fillong the questionnaire from the doctors of allopathic and

ayurvedic system. This study helps in to find out that which system is still suitable for the chronic disease. Through this customer preference toward which system has been studied. This study also shows the doctors preferences towards the combination therapy and market research from which , get the views of doctors on the diversifying system from allopathic to ayurveda. Questionnaire is totally based on straight answer from which we get the result fast and it become easy to find the appropriate views of doctors on the subject of study. The analysis leads to conclusion.

CONCLUSION
In my market survey I found weightage towards the allopathic products . 35% of allopathy doctors use ayurveda medicine in prescription but in case of ayurvedic doctors 80% of them , they are using allopathic medicine in prescription. I also find that the combination therapy made by doctors doing great job in healing the disease like coronary heart disease , cancer and many more chronicle diseases. As allopathic is first preference by the doctors but ayurveda is upcoming one. Allopathy and ayurveda are as different as day and night, and hence the two sets of opposing views. However, if one has to compare ayurveda and allopathy on one platform, then such comparison might be a tad difficult. "Allopathy treats individuals as an independent physical entity like a machine. It is further sub-divided into various organs and systems looked after by different specialties. Whereas, ayurveda treats the individual as a whole, considering him to be a part of the universal whole. A positive aspect in the whole ayurveda vs allopathy issue, is the fact that, people are now open to know more about this ancient science. Also while there might not be prejudices or bias against the same, there are certain misconceptions, which can only be dispelled with knowledge and information dissemination. "There are no prejudices surrounding ayurveda. There may be misconceptions regarding its practice. If anything, the interest in this system of medicine has been growing rapidly both in the domestic and international market, attesting to its popularity and widespread acceptance . RECOMMENDATION:

According to findings that in current scenario doctors and patient move towards the ayurveda but allopathic still rules. I would like to recommend IndSwift 1. Doctors have yet to find a solution for conditions like cancer pain and chronic pancreatitis in complementary therapies where modern interventional pain procedures are very effective. So herbal drugs use in cancer and heart disease is going to be popular for the doctors. This finding helps IndSwift to capture market by manufacturing of anti cancer herbal drug. 2. My findings helps IndSwift that it should work on herbal medicines but along with allopathic. 3. In future company get benefit if they prepare combination therapy medicines with no side effect and try to be 100% cure guarantee.

QUESTIONNAIRE: QUESTIONNAIRES ARE ATTACHED WITH THIS FILE NAMED AS QUESTIONNAIRE 01 QUESTIONNAIRE 02 BIBLIOGRAPHY: Amare G, Gedif T, Alemayehu T, Tesfahun B. Pattern of drug use in Addis Ababa community. East Afr Med J 1997;74(6):362-7. Adjei DO, Arhinful DK. Effect of training on the clinical management of malaria by medical assistants in Ghana. Soc Sci Med 1996;42(8):1169-76. Brians Klaas and Thomas W. Gainey (1999).study of Determinants of disciplinary system effectiveness. Journal of Economy and Society (1999). D.R. Cooper and P.S.Schindler, Business Research Methods 9, (2006), pp. 505 Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA et al. Long term trends in the use of complementary and alternative medical therapies in the United States. Ann Int Med 2001;250(3):262-8.

Mitzdorf U, Beck K, Horton-Hausknecht J, Weidenhammer W, Kindermann A, Takaes M et al. Why do patients seek treatment in hospitals of complementary medicine. J Altern Complement Med 1999;5(5):463-73.

Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA project. J Int Med 2001;250(3):225-33

Wexler-Morrison NE. Plural medicine in Srilanka:Do Ayurvedic and Allopathic practice differs? Soc Sci Med 1988;27:531-44 WEBSITES: http://www.extensor.co.uk/articles/medicalsystem.html http://www.allbusiness.com http://www.extensor.co.uk/article_archive.php http://www.managementparadise.com http://www.google.co.in http://www.indswift.com http://www.researharticles.com/articlesmedicalveiws.html